Deloitte Access Economics. Re-awakening Australia: the economic cost of sleep disorders in Australia, 2010. Report: Sleep Health Foundation. 2011.
Sivertsen B, Björnsdóttir E, Øverland S, Bjorvatn B, Salo P. The joint contribution of insomnia and obstructive sleep apnoea on sickness absence. J Sleep Res. 2013;22(2):223–30.
Deloitte Access Economics. Asleep on the job: costs of inadequate sleep in Australia. Report: Sleep Health Foundation. 2017.
AlGhanim N, Comondore VR, Fleetham J, Marra CA, Ayas NT. The economic impact of obstructive sleep apnea. Lung. 2008;186(1):7–12.
Hillman DR, Lack LC. Public health implications of sleep loss: the community burden. Med J Aust. 2013;199(8):S7-10.
Bin YS, Marshall NS, Glozier N. The burden of insomnia on individual function and healthcare consumption in Australia. Aust N Z J Public Health. 2012;36(5):462–8.
Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32(1):55–64.
PubMed PubMed Central Google Scholar
Botteman M. Health economics of insomnia therapy: implications for policy. Sleep Med. 2009;10(Suppl. 1):S22–5.
Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night’s sleep. Sleep Med Rev. 2016;30:72–82.
Glick DR, Abariga SA, Thomas I, Shipper AG, Gunia BC, Grandner MA, et al. Economic impact of insufficient and disturbed sleep in the workplace. Pharmacoeconomics. 2023;41(7):771–85.
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–94.
Ohayon MM. Epidemiological overview of sleep disorders in the general population. Sleep Med Res. 2011;2(1):1–9.
Thorpy MJ. Classification of sleep disorders. Neurotherapeutics. 2012;9(4):687–701.
Article PubMed PubMed Central Google Scholar
National Institutes of Health. National Institutes of Health State of the Science Conference statement on manifestations and management of chronic insomnia in adults, June 13–15, 2005. Sleep. 2005;28(9):1049–57.
Chung KF, Yeung WF, Ho FY, Yung KP, Yu YM, Kwok CW. Cross-cultural and comparative epidemiology of insomnia: the Diagnostic and Statistical Manual (DSM), International Classification of Diseases (ICD) and International Classification of Sleep Disorders (ICSD). Sleep Med. 2015;16(4):477–82.
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–33.
Appleton SL, Reynolds AC, Gill TK, Melaku YA, Adams RJ. Insomnia prevalence varies with symptom criteria used with implications for epidemiological studies: role of anthropometrics, sleep habit, and comorbidities. Nat Sci Sleep. 2022;14:775–90.
Article PubMed PubMed Central Google Scholar
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70–81.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.
Article CAS PubMed Google Scholar
Lechat B, Naik G, Reynolds A, Aishah A, Scott H, Loffler KA, et al. Multinight prevalence, variability, and diagnostic misclassification of obstructive sleep apnea. Am J Respir Crit Care Med. 2022;205(5):563–9.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034–41.
Article CAS PubMed Google Scholar
Lechat B, Appleton S, Melaku YA, Hansen K, McEvoy RD, Adams R, et al. The association of co-morbid insomnia and sleep apnea with prevalent cardiovascular disease and incident cardiovascular events. J Sleep Res. 2022;31(5): e13563.
Krishnan S, Chai-Coetzer CL, Grivell N, Lovato N, Mukherjee S, Vakulin A, et al. Comorbidities and quality of life in Australian men and women with diagnosed and undiagnosed high-risk obstructive sleep apnea. J Clin Sleep Med. 2022;18(7):1757–67.
Article PubMed PubMed Central Google Scholar
Lechat B, Appleton S, Melaku YA, Hansen K, McEvoy RD, Adams R, et al. Comorbid insomnia and sleep apnoea is associated with all-cause mortality. Eur Respir J. 2022;60(1):2101958.
Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med. 1999;340(11):847–51.
Hafner M, Stepanek M, Taylor J, Troxel WM, van Stolk C. Why sleep matters: the economic costs of insufficient sleep: a cross-country comparative analysis. Rand Health Q. 2017;6(4):11.
PubMed PubMed Central Google Scholar
Streatfeild J, Smith J, Mansfield D, Pezzullo L, Hillman D. The social and economic cost of sleep disorders. Sleep. 2021. https://doi.org/10.1093/sleep/zsab132.
Hillman D, Mitchell S, Streatfeild J, Burns C, Bruck D, Pezzullo L. The economic cost of inadequate sleep. Sleep. 2018. https://doi.org/10.1093/sleep/zsy083.
Organisation for Economic Co-operation and Development. Health expenditure. 2022. Available from: https://www.oecd.org/els/health-systems/health-expenditure.htm. [Accessed 11 Apr 2023].
Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74.
Article CAS PubMed Google Scholar
Brazier J, Ratcliffe J, Saloman J, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. 2nd ed. Oxford: Oxford University Press; 2017.
Drummond M, Sculphe M, Torrance G, O’Brien B, Stoddart G. Methods for the economic evaluation of health care programs. New York: Oxford University Press; 2015.
Natsky AN, Vakulin A, Chai-Coetzer CL, Lack L, McEvoy RD, Lovato N, et al. Economic evaluation of cognitive behavioural therapy for insomnia (CBT-I) for improving health outcomes in adult populations: a systematic review. Sleep Med Rev. 2020;54: 101351.
Kaambwa B, Mpundu-Kaambwa C, Adams R, Appleton S, Martin S, Wittert G. Suitability of the Epworth Sleepiness Scale (ESS) for economic evaluation: an aasessment of its convergent and discriminant validity. Behav Sleep Med. 2018;16(5):448–70.
Bonin EM, Beecham J, Swift N, Raikundalia S, Brown JS. Psycho-educational CBT-Insomnia workshops in the community: a cost-effectiveness analysis alongside a randomised controlled trial. Behav Res Ther. 2014;55:40–7.
Hofmeister D, Schulte T, Mehnert-Theuerkauf A, Geue K, Zenger M, Esser P, et al. The association between sleep problems and general quality of life in cancer patients and in the general population. Front Psychol. 2022;13: 960029.
Article PubMed PubMed Central Google Scholar
Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med. 1998;158(2):494–503.
Article CAS PubMed Google Scholar
Uchmanowicz I, Markiewicz K, Uchmanowicz B, Kołtuniuk A, Rosińczuk J. The relationship between sleep disturbances and quality of life in elderly patients with hypertension. Clin Interv Aging. 2019;14:155–65.
Article PubMed PubMed Central Google Scholar
Lee S, Kim JH, Chung JH. The association between sleep quality and quality of life: a population-based study. Sleep Med. 2021;84:121–6.
Article CAS PubMed Google Scholar
Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26(2):117–26.
Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003;12(1):1–12.
Messick S. Test validity and the ethics of assessment. Am Psychol. 1980;35(11):1012–27.
World Health Organization. Towards a common language for functioning, disability and health ICF: the international classification of functioning, disability and health. Geneva: World Health Organization; 2002.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1–9.
留言 (0)